Superworth

Moderna shares outstanding MRNA

Diluted shares outstanding, averaged over each quarter, from 2018.

Latest quarter, to Jun 30, 2026
398M
On a year earlier
+2.6%
more shares

Moderna had 398M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.

That is 2.6% more than a year earlier, so each share owns a little less of the company.

Shares outstanding over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearShares, fourth quarterChange
FY2025392M+1%
FY2024387M+1%
FY2023382M−6%
FY2022407M−6%
FY2021431M+9%
FY2020396.7M+19%
FY2019334.4M+165%
FY2018126.3Mn/a

Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.

Quarter by quarter

QuarterEndedShares outstandingOn a year earlier
Q2 FY26398M+3%
Q1 FY26395M+2%
Q4 FY25392M+1%
Q3 FY25390M−2%
Q2 FY25388M+1%
Q1 FY25386M+1%
Q4 FY24387M+1%
Q3 FY24399M+5%
Q2 FY24384M+1%
Q1 FY24382M−6%
Q4 FY23382M−6%
Q3 FY23381M−8%

What the shares outstanding tells you

Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.

A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.

More on Moderna

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.